Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Auli Ropo, M.D.
Santen Oy
Study Director - Clemens Vass, M.D.
Medical University Vienna, Austria
Principal Investigator - Eva Ruzickova, M.D.
Vseobecna fakultni nemocnice v Praze, Czech Republic
Principal Investigator - Guna Laganovska, M.D.
P. Stradina Clinical University Hospital, Latvia
Principal Investigator - Gábor Holló
Semmelweis Egyetem, Hungary
Principal Investigator - Julián García-Feijóo, M.D.
Hospital Clinico San Carlos, Spain
Principal Investigator - Maria L. Ribeiro, M.D.
Aibili-Associação p/ Investigação Biomédica e Inovação em Luz e Imagem (AIBILI), Portugal
Principal Investigator - Marieta Kostianeva, M.D.
University Mulitiprofile Hospital for Active Treatment Sv.Georgi, Bulgaria
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Debrecen, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 30 Apr 2012
- Completion
- 31 May 2012
- Last update posted
- 8 Jun 2012
- Registered enrollment
- 401
- Registry id
- NCT01306461
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.